316 related articles for article (PubMed ID: 9533475)
1. Activity of azithromycin, clarithromycin, roxithromycin, dirithromycin, quinupristin/dalfopristin and erythromycin against Legionella species by intracellular susceptibility testing in HL-60 cells.
Stout JE; Arnold B; Yu VL
J Antimicrob Chemother; 1998 Feb; 41(2):289-91. PubMed ID: 9533475
[TBL] [Abstract][Full Text] [Related]
2. Comparative activity of ciprofloxacin, ofloxacin, levofloxacin, and erythromycin against Legionella species by broth microdilution and intracellular susceptibility testing in HL-60 cells.
Stout JE; Arnold B; Yu VL
Diagn Microbiol Infect Dis; 1998 Jan; 30(1):37-43. PubMed ID: 9488830
[TBL] [Abstract][Full Text] [Related]
3. In vitro activity of macrolides against intracellular Legionella pneumophila.
Segreti J; Meyer P; Kapell K
Diagn Microbiol Infect Dis; 1996 Jul; 25(3):123-6. PubMed ID: 8902407
[TBL] [Abstract][Full Text] [Related]
4. Susceptibility of penicillin-susceptible and -resistant pneumococci to dirithromycin compared with susceptibilities to erythromycin, azithromycin, clarithromycin, roxithromycin, and clindamycin.
Visalli MA; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 1997 Sep; 41(9):1867-70. PubMed ID: 9303375
[TBL] [Abstract][Full Text] [Related]
5. A review of the in-vitro activity of quinupristin/dalfopristin against intracellular pathogens and mycoplasmas.
Bébéar C; Bouanchaud DH
J Antimicrob Chemother; 1997 May; 39 Suppl A():59-62. PubMed ID: 9511064
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial activity of ten macrolide, lincosamine and streptogramin drugs tested against Legionella species.
Johnson DM; Erwin ME; Barrett MS; Gooding BB; Jones RN
Eur J Clin Microbiol Infect Dis; 1992 Aug; 11(8):751-5. PubMed ID: 1425738
[TBL] [Abstract][Full Text] [Related]
7. Intracellular activity of ABT-773 and other antimicrobial agents against Legionella pneumophila.
Jung R; Danziger LH; Pendland SL
J Antimicrob Chemother; 2002 May; 49(5):857-61. PubMed ID: 12003984
[TBL] [Abstract][Full Text] [Related]
8. Comparative activity of quinolones, macrolides and ketolides against Legionella species using in vitro broth dilution and intracellular susceptibility testing.
Stout JE; Sens K; Mietzner S; Obman A; Yu VL
Int J Antimicrob Agents; 2005 Apr; 25(4):302-7. PubMed ID: 15784309
[TBL] [Abstract][Full Text] [Related]
9. [Comparative antimicrobial activity of RP 59,500 (quinupristin-dalfopristin), the first semisynthetic injectable streptgramin, against gram-positive cocci and other recent clinical pathogens].
Nakashio S; Iwasawa H; Iino S; Shimada J
Jpn J Antibiot; 1997 Oct; 50(10):844-53. PubMed ID: 9412874
[TBL] [Abstract][Full Text] [Related]
10. Antibacterial activities of gemifloxacin, levofloxacin, gatifloxacin, moxifloxacin and erythromycin against intracellular Legionella pneumophila and Legionella micdadei in human monocytes.
Baltch AL; Bopp LH; Smith RP; Michelsen PB; Ritz WJ
J Antimicrob Chemother; 2005 Jul; 56(1):104-9. PubMed ID: 15941776
[TBL] [Abstract][Full Text] [Related]
11. The in vitro activity of some 14-, 15- and 16- membered macrolides against Staphylococcus spp., Legionella spp., Mycoplasma spp. and Ureaplasma urealyticum.
Felmingham D; Robbins MJ; Sanghrajka M; Leakey A; Ridgway GL
Drugs Exp Clin Res; 1991; 17(2):91-9. PubMed ID: 1650694
[TBL] [Abstract][Full Text] [Related]
12. Susceptibility of Streptococcus pyogenes to azithromycin, clarithromycin, erythromycin and roxithromycin in vitro.
Van Asselt GJ; Sloos JH; Mouton RP; Van Boven CP; Van de Klundert JA
J Med Microbiol; 1995 Nov; 43(5):386-91. PubMed ID: 7563004
[TBL] [Abstract][Full Text] [Related]
13. [Activity of macrolides and fluoroquinolones against intracellular Legionella pneumophila].
Yu LL; Hu BJ; Huang SL; Zhou ZY; Tao LL
Zhonghua Jie He He Hu Xi Za Zhi; 2011 Jun; 34(6):409-12. PubMed ID: 21781510
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of quinupristin/dalfopristin (Synercid, RP 59500) against Legionella spp.
Edelstein PH; Edelstein MA
Diagn Microbiol Infect Dis; 2000 Jan; 36(1):49-52. PubMed ID: 10744367
[TBL] [Abstract][Full Text] [Related]
15. Review of azithromycin activity against Legionella spp.
Edelstein PH
Pathol Biol (Paris); 1995 Jun; 43(6):569-72. PubMed ID: 8539085
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of pazufloxacin, tosufloxacin and other quinolones against Legionella species.
Higa F; Akamine M; Haranaga S; Tohyama M; Shinzato T; Tateyama M; Koide M; Saito A; Fujita J
J Antimicrob Chemother; 2005 Dec; 56(6):1053-7. PubMed ID: 16260445
[TBL] [Abstract][Full Text] [Related]
17. The new macrolide antibiotics: azithromycin, clarithromycin, dirithromycin, and roxithromycin.
Bahal N; Nahata MC
Ann Pharmacother; 1992 Jan; 26(1):46-55. PubMed ID: 1318761
[TBL] [Abstract][Full Text] [Related]
18. In vitro activities of eight macrolide antibiotics and RP-59500 (quinupristin-dalfopristin) against viridans group streptococci isolated from blood of neutropenic cancer patients.
Alcaide F; Carratala J; Liñares J; Gudiol F; Martin R
Antimicrob Agents Chemother; 1996 Sep; 40(9):2117-20. PubMed ID: 8878591
[TBL] [Abstract][Full Text] [Related]
19. Comparison of charcoal- and starch-based media for testing susceptibilities of Legionella species to macrolides, azalides, and fluoroquinolones.
Pendland SL; Martin SJ; Chen C; Schreckenberger PC; Danziger LH
J Clin Microbiol; 1997 Nov; 35(11):3004-6. PubMed ID: 9350781
[TBL] [Abstract][Full Text] [Related]
20. In vitro activity of various antibiotics against clinical strains of Legionella species isolated in Japan.
Miyashita N; Kobayashi I; Higa F; Aoki Y; Kikuchi T; Seki M; Tateda K; Maki N; Uchino K; Ogasawara K; Kurachi S; Ishikawa T; Ishimura Y; Kanesaka I; Kiyota H; Watanabe A
J Infect Chemother; 2018 May; 24(5):325-329. PubMed ID: 29459000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]